Acrophobia clinical trials
The registry lists 22 studies for Acrophobia across 8 countries. 0 are recruiting or about to start. 16 of them are mainly about Acrophobia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-22.
Who runs them
University of Texas at Austin (3) · Ruhr University of Bochum (3) · University of Notre Dame (1) · University Hospital Tuebingen (1) · CAMC Health System (1) · University of Nevada, Reno (1) · Nantes University Hospital (1) · Wuerzburg University Hospital (1)
Who these studies take
No Acrophobia study is recruiting now.
Across all 22 studies, recruiting or not: 82% stop at 75 or younger and 77% at 65; 0% take children; 0% are for women only and 0% for men only; 59% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Acrophobia studies take
Of 11 interventional studies with no phase under Acrophobia, half reached primary completion within 11 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 11 mo6–16 · 11 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Results posted1
- D-Cycloserine-Enhancer of One-Session Treatment for Phobia of HeightsOct 22, 2026NCT01037101
Stopped1
- D-Cycloserine-Enhancer of One-Session Treatment for Phobia of HeightsTerminatedOct 22, 2026NCT01037101
Studies
Recruiting first, then most recently updated. Showing 22 of 22. search them.
- D-Cycloserine-Enhancer of One-Session Treatment for Phobia of HeightsTerminatedNCT01037101Phase 21 country
- Virtual Reality and Brain Stimulation, an Experiential ApproachCompletedNCT03387254Not applicable1 country
- Virtual Reality Intervention for Fear of HeightsCompletedNCT06468878Not applicable1 country
- Self-efficacy Enhancement in a Virtual Reality Training for Fear of HeightsCompletedNCT05824884Not applicable1 country
- Hypnosis Induction and Height Experience in VR - Control Group Comparison and Three SessionsActive, not recruitingNCT06618456Not applicable1 country
- Virtual Reality Exposure Therapy for AcrophobiaCompletedNCT04975854Not applicable1 country
- CBM in the Context of Exposure for AcrophobiaCompletedNCT05780203Not applicable1 country
- Psychotherapy of Anxiety Disorders With Noninvasive Brain Stimulation - Using Virtual RealityCompletedNCT04782570Not applicable1 country
- Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in AcrophobiaCompletedNCT05841329Not applicable1 country
- Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After ExposureCompletedNCT03907345Not applicable1 country
- Augmenting Virtual Reality Exposure Therapy for AcrophobiaSuspendedNCT03917433Not applicable1 country
- Virtual Reality Exposure Versus In Vivo Exposure for Fear of HeightsCompletedNCT04737915Not applicable1 country
- Intelligent Virtual Reality Therapy System and Testing Its Clinical EfficacyCompletedNCT04620447Phase 1/21 country
- Efficacy of a VR Paradigm to Reduce Fear of Heights in a Clinical and Subclinical Population With Fear of HeightsCompletedNCT04003753Not applicable1 country
- Single Session Virtual Reality Therapy in Acrophobia - and the Role of RespirationStatus unknownNCT03893214Not applicable
- Anti-phobic and Safety Behaviors in the Treatment of AcrophobiaStatus unknownNCT02085343Not applicable1 country
- 3D Video Virtual Reality Exposure Therapy StudyStatus unknownNCT02584387Not applicable1 country
- Exercise and Virtual Reality Exposure Therapy for AcrophobiaCompletedNCT02361203Not applicable1 country
- Virtual Reality and Concept of Control in the Treatment of AcrophobiaStatus unknownNCT02020824Not applicable1 country
- Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic ParticipantsCompletedNCT02007694Phase 2/31 country
- D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for AcrophobiaCompletedNCT01102803Phase 31 country
- Changes in Brain Activity (Functional MRI Study) Before and After Behavioral Therapy of Height PhobiaCompletedNCT00302978Not applicable